Skip to main content

Table 2 Baseline characteristics

From: The eNOS 894G/T gene polymorphism and its influence on early and long-term mortality after on-pump cardiac surgery

Variable GG GT TT p value
  (n = 251) (n = 210) (n = 39)  
Age (years) 68 ± 10 67 ± 11 68 ± 9 0.97
Male/female 163/88 134/76 26/13 0.93
Risk factors     
 Body mass index (kg/m2) 28 ± 4.6 27. ± 4.8 27 ± 4.5 0.18
 Smoking 85 66 16 0.49
 Hypertension 184 144 34 0.05
 Hypercholesterolemia 125 95 21 0.48
 Diabetes mellitus 78 63 13 0.91
 Positive family history 40 31 8 0.66
 Ejection fraction (%) 53 ± 14 52 ± 15 62 ± 10 0.07
 Renal disorder 29 33 6 0.41
 Peripheral disease 17 12 6 0.09
 Neurocerebral events 36 26 4 0.70
 Pulmonary hypertension 26 11 3 0.13
 COPD 18 18 4 0.74
 Dialysis 1 2 0 0.66
Preoperative medications     
 ß-blockers 158 129 29 0.31
 ACE inhibitors 135 103 25 0.19
 Oral nitrates 55 33 5 0.15
 Antiarrhythmics 11 7 1 0.77
 Diuretics 106 80 13 0.46
 Antilipid agents 119 94 25 0.08
 Antidiabetics 51 35 8 0.58
 Antihypertensive agents 54 49 8 0.87
 Bronchodilators 6 8 1 0.66
 Anticoagulation 163 145 29 0.40
 Urgency of surgery     
 Elective (n = 396) 202 161 33 0.41
 Urgent (n = 41) 26 13 2 0.21
 Emergency (n = 63) 23 36 4 0.03
Associated surgical procedures     
 CABG (n = 251) 118 111 22 0.26
 Valve (n = 107) 58 44 5 0.32
 Combined procedures (n = 101) 55 36 10 0.36
 Other procedures (n = 41) 20 19 2 0.78
 Euroscore additive 5 ± 4 6 ± 4 5 ± 3 0.19
  1. COPD: chronic obstructive pulmonary disease, ACE: angiotensin-converting enzyme, CABG: Coronary artery bypass grafting.